Literature DB >> 11477628

Volume correction for edema in single-volume proton MR spectroscopy of contrast-enhancing multiple sclerosis lesions.

G Helms1.   

Abstract

The effect of edema on metabolic changes in contrast-enhancing multiple sclerosis lesions was studied by combining quantification of proton MR spectra with segmentation of the volume-of-interest, which was based on biexponential T(2) relaxation. All lesions showed a second component (s(long)) with a longer T(2) (185-450 ms), which was increased compared to healthy controls. Regression analysis indicated that s(long) replaces the short-T(2) component and total creatine. Since the water content was close to 100%, s(long) was used to correct for an increase in extracellular space. This compensated for the apparent loss of creatine and rendered cholines markedly increased, as observed in animals with experimental allergic encephalomyelitis. Total N-acetyl aspartate (NAA) concentration was inversely correlated with s(long) and between 34-70% of its average reduction was assigned to edema. Thus, NAA loss exceeded cellular loss. Assessment of varying degrees of edema may be especially beneficial for quantitative longitudinal studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11477628     DOI: 10.1002/mrm.1186

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  15 in total

1.  The role of relaxation time corrections for the evaluation of long and short echo time 1H MR spectra of the hippocampus by NUMARIS and LCModel techniques.

Authors:  Filip Jírů; Monika Dezortová; Martin Burian; Milan Hájek
Journal:  MAGMA       Date:  2003-10-16       Impact factor: 2.310

2.  T2-based segmentation of periventricular paragraph sign volumes for quantification of proton magnetic paragraph sign resonance spectra of multiple sclerosis lesions.

Authors:  Gunther Helms
Journal:  MAGMA       Date:  2003-02       Impact factor: 2.310

Review 3.  Imaging of multiple sclerosis: role in neurotherapeutics.

Authors:  Rohit Bakshi; Alireza Minagar; Zeenat Jaisani; Jerry S Wolinsky
Journal:  NeuroRx       Date:  2005-04

Review 4.  Recent advances in magnetic resonance neurospectroscopy.

Authors:  Yael Rosen; Robert E Lenkinski
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

5.  Impact of frequency drift on gamma-aminobutyric acid-edited MR spectroscopy.

Authors:  Ashley D Harris; Benjamin Glaubitz; Jamie Near; C John Evans; Nicolaas A J Puts; Tobias Schmidt-Wilcke; Martin Tegenthoff; Peter B Barker; Richard A E Edden
Journal:  Magn Reson Med       Date:  2013-11-11       Impact factor: 4.668

6.  Normalizing data from GABA-edited MEGA-PRESS implementations at 3 Tesla.

Authors:  Ashley D Harris; Nicolaas A J Puts; S Andrea Wijtenburg; Laura M Rowland; Mark Mikkelsen; Peter B Barker; C John Evans; Richard A E Edden
Journal:  Magn Reson Imaging       Date:  2017-05-04       Impact factor: 2.546

7.  Spectral-editing measurements of GABA in the human brain with and without macromolecule suppression.

Authors:  Ashley D Harris; Nicolaas A J Puts; Peter B Barker; Richard A E Edden
Journal:  Magn Reson Med       Date:  2014-12-17       Impact factor: 4.668

Review 8.  The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.

Authors:  Gerwyn Morris; Michael Berk; Piotr Galecki; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-01-20       Impact factor: 5.590

Review 9.  MRI in multiple sclerosis: current status and future prospects.

Authors:  Rohit Bakshi; Alan J Thompson; Maria A Rocca; Daniel Pelletier; Vincent Dousset; Frederik Barkhof; Matilde Inglese; Charles R G Guttmann; Mark A Horsfield; Massimo Filippi
Journal:  Lancet Neurol       Date:  2008-07       Impact factor: 44.182

10.  Synthetic signal injection using inductive coupling.

Authors:  Kenneth I Marro; Donghoon Lee; Eric G Shankland; Clinton M Mathis; Cecil E Hayes; Catherine E Amara; Martin J Kushmerick
Journal:  J Magn Reson       Date:  2008-07-01       Impact factor: 2.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.